Delta Air Lines shares could finally take off this year once enough investors can shake off unmerited worries. Drugmaker Amgen's singles and doubles approach to the business makes more sense than alwa
A couple of big-picture trends in biotech could add up to a nice investment opportunity. First, corporate buyouts are back in style.
Planning Underway for Phase 3 Development of Tezepelumab in COPD   THOUSAND OAKS, Calif. , April 16, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today provided an update regarding the results of the Pha
Due to its obvious nature, one of the most commonly repeated pieces of advice regarding stock investment is to buy undervalued stocks when they trade low and sell overvalued stocks when they trade hig
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Amgen: I Prefer To Chase Value And Dividends

08:15am, Monday, 15'th Apr 2024
Amgen has a history of outperforming peers and the market due to its effective capital allocation in the pharmaceutical industry. AMGN is executing well with sales and volume growth, and has a robust

Amgen: The Giant With An Impressive Pipeline

04:25am, Monday, 15'th Apr 2024
Amgen's acquisition of Horizon Therapeutics has made it a major player in the rare disease space, with potential for long-term shareholder return. The company has key pipeline milestones in 2024, focu

Final Trades: Shell, 2-YR T-Note and Amgen

02:10pm, Friday, 12'th Apr 2024
The Investment Committee give you their top stocks to watch for the second half.

Amgen (AMGN) Laps the Stock Market: Here's Why

07:06pm, Thursday, 11'th Apr 2024
In the most recent trading session, Amgen (AMGN) closed at $270, indicating a +1.33% shift from the previous trading day.

Is Amgen Stock a Buy?

08:00am, Thursday, 11'th Apr 2024
Amgen has been busy with a couple of multi-billion dollar acquisitions over the past few years. While they should create growth opportunities, the drugmaker has also taken on quite a bit of debt.
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
Looking ahead, the future of the U.S. economy appears promising despite ongoing challenges. President Biden's efforts to steer the economy through inflation concerns are showing strong results.

2 Biotech Stocks to Buy Hand Over Fist in April

08:45am, Saturday, 06'th Apr 2024
Amgen's lineup and pipeline should help its financial results and keep its dividend intact. While lesser known, Sarepta is proving itself to be a highly innovative biotech company.
Amgen (AMGN) concluded the recent trading session at $269.95, signifying a +0.69% move from its prior day's close.
As the retirement crisis looms, urgent action is key. The financial industry's failure to address rising retirement costs exacerbates the situation. Investing in dividend-growth stocks emerges as a cr
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE